With 0.63 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.33 million shares. The 52-week range on ASTH shows that it touched its highest point at $63.20 and its lowest point at $23.12 during that stretch. It currently has a 1-year price target of $52.60. Beta for the stock currently stands at 1.30.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ASTH was down-trending over the past week, with a drop of -23.45%, but this was down by -28.08% over a month. Three-month performance dropped to -37.64% while six-month performance fell -45.15%. The stock lost -39.50% in the past year, while it has lost -16.02% so far this year. A look at the trailing 12-month EPS for ASTH yields 0.89 with Next year EPS estimates of 1.78. For the next quarter, that number is 0.33. This implies an EPS growth rate of 44.95% for this year and 36.56% for next year. EPS is expected to grow by 40.48% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 18.34%.
Float and Shares Shorts:
At present, 47.93 million ASTH shares are outstanding with a float of 36.62 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ASTH since 5 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $1.2249 being high and $1.06685 being low. For ASTH, this leads to a yearly average estimate of $1.136. Based on analyst estimates, the high estimate for the next quarter is $0.4 and the low estimate is $0.4. The average estimate for the next quarter is thus $0.4.
Summary of Insider Activity:
Insiders traded ASTH stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.
